Chemical
Browse
Active Pharmaceutical Ingredients
Bioactive chemicals
Agrochemicals
Search
Chemical Structure
Explore
Chemical Similarity
Transformation
Browse
Prodrugs
Drug Metabolites
Metabolite Datasets
Biochemical Action
Browse
Target Level (ChEMBL)
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Mechanism of action
Search
Mechanism of action
BLAST against human drug target
BLAST against selected species (UniProt)
Exposure
Browse
Monitoring data
Downloads
Web services
Bulk downloads
About
About EcoDrug+
Citing
Data Sources
Contact Us
Versions and log file
Display Options:
Molecule Type
Mechanism of Action
Route of Adminstration
Status
Therapeutic Indication
Number of compounds:
7959
ITRACONAZOLE
(1992)
Small molecule
Cytochrome P450 51 inhibitor
INJECTION; ORAL
Approved
Aspergillosis; Blastomycosis; Candidiasis; Lung Diseases; Mycoses; Onychomycosis
ITRACONAZOLE
×
Maximum Phase:
4
First Approval:
1992
UNII:
304NUG5GF4
Molecule Type:
Small molecule
Molecular Formula:
C35H38Cl2N8O4
Molecular Weight:
705.65
AlogP:
5.58
PSA:
104.7
HBD:
0.0
HBA:
#RotB:
11.0
Source:
RIFABUTIN
(1992)
Small molecule
Bacterial DNA-directed RNA polymerase inhibitor
ORAL
Approved
HIV Infections; Mycobacterium avium-intracellulare Infection; Tuberculosis
RIFABUTIN
×
Maximum Phase:
4
First Approval:
1992
UNII:
1W306TDA6S
Molecule Type:
Small molecule
Molecular Formula:
C46H62N4O11
Molecular Weight:
847.02
AlogP:
4.62
PSA:
205.55
HBD:
5.0
HBA:
#RotB:
4.0
Source:
TENIPOSIDE
(1992)
Small molecule
DNA topoisomerase II inhibitor
INJECTION
Approved
Neoplasms
TENIPOSIDE
×
Maximum Phase:
4
First Approval:
1992
UNII:
957E6438QA
Molecule Type:
Small molecule
Molecular Formula:
C32H32O13S
Molecular Weight:
656.66
AlogP:
2.75
PSA:
160.83
HBD:
3.0
HBA:
#RotB:
6.0
Source:
MASOPROCOL
(1992)
Small molecule
Unknown
TOPICAL
Approved
Neoplasms
MASOPROCOL
×
Maximum Phase:
4
First Approval:
1992
UNII:
7BO8G1BYQU
Molecule Type:
Small molecule
Molecular Formula:
C18H22O4
Molecular Weight:
302.37
AlogP:
3.57
PSA:
80.92
HBD:
4.0
HBA:
#RotB:
5.0
Source:
PAROXETINE
(1992)
Small molecule
Unknown
Unknown
Approved
Depressive Disorder
PAROXETINE
×
Maximum Phase:
4
First Approval:
1992
UNII:
41VRH5220H
Molecule Type:
Small molecule
Molecular Formula:
C19H20FNO3
Molecular Weight:
329.37
AlogP:
3.33
PSA:
39.72
HBD:
1.0
HBA:
#RotB:
4.0
Source:
SOTALOL
(1992)
Small molecule
Unknown
Unknown
Approved
Cardiovascular Diseases
SOTALOL
×
Maximum Phase:
4
First Approval:
1992
UNII:
A6D97U294I
Molecule Type:
Small molecule
Molecular Formula:
C12H20N2O3S
Molecular Weight:
272.37
AlogP:
1.09
PSA:
78.43
HBD:
3.0
HBA:
#RotB:
6.0
Source:
TERBINAFINE HYDROCHLORIDE
(1992)
Small molecule
Squalene monooxygenase inhibitor
ORAL; TOPICAL
Approved
Unknown
TERBINAFINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
1992
UNII:
012C11ZU6G
Molecule Type:
Small molecule
Molecular Formula:
C21H26ClN
Molecular Weight:
327.9
AlogP:
4.88
PSA:
3.24
HBD:
0.0
HBA:
#RotB:
4.0
Source:
DESOGESTREL
(1992)
Small molecule
Progesterone receptor agonist
Unknown
Approved
Unknown
DESOGESTREL
×
Maximum Phase:
4
First Approval:
1992
UNII:
81K9V7M3A3
Molecule Type:
Small molecule
Molecular Formula:
C22H30O
Molecular Weight:
310.48
AlogP:
4.87
PSA:
20.23
HBD:
1.0
HBA:
#RotB:
1.0
Source:
TEMAFLOXACIN
(1992)
Small molecule
Unknown
Unknown
Approved
Bacterial Infections
TEMAFLOXACIN
×
Maximum Phase:
4
First Approval:
1992
UNII:
1WZ12GTT67
Molecule Type:
Small molecule
Molecular Formula:
C21H18F3N3O3
Molecular Weight:
417.39
AlogP:
2.9
PSA:
74.57
HBD:
2.0
HBA:
#RotB:
3.0
Source:
HALOFANTRINE
(1992)
Small molecule
Unknown
Unknown
Approved
Malaria
HALOFANTRINE
×
Maximum Phase:
4
First Approval:
1992
UNII:
R7ADS21FSN
Molecule Type:
Small molecule
Molecular Formula:
C26H30Cl2F3NO
Molecular Weight:
500.43
AlogP:
8.64
PSA:
23.47
HBD:
1.0
HBA:
#RotB:
10.0
Source:
PERINDOPRIL ERBUMINE
(1993)
Small molecule
Angiotensin-converting enzyme inhibitor
ORAL
Approved
Coronary Artery Disease; Hypertension
PERINDOPRIL ERBUMINE
×
Maximum Phase:
4
First Approval:
1993
UNII:
1964X464OJ
Molecule Type:
Small molecule
Molecular Formula:
C23H43N3O5
Molecular Weight:
441.61
AlogP:
1.94
PSA:
95.94
HBD:
2.0
HBA:
#RotB:
8.0
Source:
LEVOMETHADYL ACETATE HYDROCHLORIDE
(1993)
Small molecule
Mu opioid receptor agonist
ORAL
Approved
Unknown
LEVOMETHADYL ACETATE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
1993
UNII:
B54CW5KG52
Molecule Type:
Small molecule
Molecular Formula:
C23H32ClNO2
Molecular Weight:
389.97
AlogP:
4.65
PSA:
29.54
HBD:
0.0
HBA:
#RotB:
8.0
Source:
FENOFIBRATE
(1993)
Small molecule
Peroxisome proliferator-activated receptor alpha agonist
ORAL
Approved
Cardiovascular Diseases; Diabetes Mellitus; Diabetes Mellitus, Type 2; Dyslipidemias; Hypercholesterolemia; Hypothyroidism
FENOFIBRATE
×
Maximum Phase:
4
First Approval:
1993
UNII:
U202363UOS
Molecule Type:
Small molecule
Molecular Formula:
C20H21ClO4
Molecular Weight:
360.84
AlogP:
4.68
PSA:
52.6
HBD:
0.0
HBA:
#RotB:
6.0
Source:
RISPERIDONE
(1993)
Small molecule
Dopamine D2 receptor antagonist
INTRAMUSCULAR; ORAL; SUBCUTANEOUS
Approved
Aggression; Autistic Disorder; Bipolar Disorder; Psychotic Disorders; Schizophrenia
RISPERIDONE
×
Maximum Phase:
4
First Approval:
1993
UNII:
L6UH7ZF8HC
Molecule Type:
Small molecule
Molecular Formula:
C23H27FN4O2
Molecular Weight:
410.49
AlogP:
3.59
PSA:
64.16
HBD:
0.0
HBA:
#RotB:
4.0
Source:
PERINDOPRIL
(1993)
Small molecule
Unknown
Unknown
Approved
Cardiovascular Diseases
PERINDOPRIL
×
Maximum Phase:
4
First Approval:
1993
UNII:
Y5GMK36KGY
Molecule Type:
Small molecule
Molecular Formula:
C19H32N2O5
Molecular Weight:
368.47
AlogP:
1.94
PSA:
95.94
HBD:
2.0
HBA:
#RotB:
8.0
Source:
LODOXAMIDE
(1993)
Small molecule
Unknown
Unknown
Approved
Eye Manifestations
LODOXAMIDE
×
Maximum Phase:
4
First Approval:
1993
UNII:
SPU695OD73
Molecule Type:
Small molecule
Molecular Formula:
C11H6ClN3O6
Molecular Weight:
311.64
AlogP:
0.26
PSA:
156.59
HBD:
4.0
HBA:
#RotB:
2.0
Source:
TAZOBACTAM
(1993)
Small molecule
Unknown
Unknown
Approved
Bacterial Infections
TAZOBACTAM
×
Maximum Phase:
4
First Approval:
1993
UNII:
SE10G96M8W
Molecule Type:
Small molecule
Molecular Formula:
C10H12N4O5S
Molecular Weight:
300.3
AlogP:
-1.52
PSA:
122.46
HBD:
1.0
HBA:
#RotB:
3.0
Source:
GRANISETRON HYDROCHLORIDE
(1993)
Small molecule
Serotonin 3a (5-HT3a) receptor antagonist
INJECTION; ORAL
Approved
Nausea; Postoperative Nausea and Vomiting
GRANISETRON HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
1993
UNII:
318F6L70J8
Molecule Type:
Small molecule
Molecular Formula:
C18H25ClN4O
Molecular Weight:
348.88
AlogP:
2.32
PSA:
50.16
HBD:
1.0
HBA:
#RotB:
2.0
Source:
STRONTIUM CHLORIDE SR 89
(1993)
Small molecule
Unknown
Unknown
Approved
Neoplasm Metastasis
STRONTIUM CHLORIDE SR 89
×
Maximum Phase:
4
First Approval:
1993
UNII:
5R78837D4A
Molecule Type:
Small molecule
Molecular Formula:
Cl2Sr
Molecular Weight:
159.81
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
PERFLUBRON
(1993)
Small molecule
Unknown
ORAL
Approved
Unknown
PERFLUBRON
×
Maximum Phase:
4
First Approval:
1993
UNII:
Q1D0Q7R4D9
Molecule Type:
Small molecule
Molecular Formula:
C8BrF17
Molecular Weight:
498.96
AlogP:
6.35
PSA:
0.0
HBD:
0.0
HBA:
#RotB:
6.0
Source:
GADODIAMIDE
(1993)
Small molecule
Diagnostic agent
INJECTION
Approved
Unknown
GADODIAMIDE
×
Maximum Phase:
4
First Approval:
1993
UNII:
84F6U3J2R6
Molecule Type:
Small molecule
Molecular Formula:
C16H26GdN5O8
Molecular Weight:
573.66
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
TRIMETREXATE
(1993)
Small molecule
Unknown
Unknown
Approved
Unknown
TRIMETREXATE
×
Maximum Phase:
4
First Approval:
1993
UNII:
UPN4ITI8T4
Molecule Type:
Small molecule
Molecular Formula:
C19H23N5O3
Molecular Weight:
369.43
AlogP:
2.74
PSA:
117.54
HBD:
3.0
HBA:
#RotB:
6.0
Source:
RIMANTADINE
(1993)
Small molecule
Unknown
Unknown
Approved
Virus Diseases
RIMANTADINE
×
Maximum Phase:
4
First Approval:
1993
UNII:
0T2EF4JQTU
Molecule Type:
Small molecule
Molecular Formula:
C12H21N
Molecular Weight:
179.31
AlogP:
2.55
PSA:
26.02
HBD:
1.0
HBA:
#RotB:
1.0
Source:
LORATADINE
(1993)
Small molecule
Histamine H1 receptor antagonist
Unknown
Approved
Hypersensitivity; Pruritus; Rhinitis, Allergic, Perennial; Rhinitis, Allergic, Seasonal; Urticaria
LORATADINE
×
Maximum Phase:
4
First Approval:
1993
UNII:
7AJO3BO7QN
Molecule Type:
Small molecule
Molecular Formula:
C22H23ClN2O2
Molecular Weight:
382.89
AlogP:
4.89
PSA:
42.43
HBD:
0.0
HBA:
#RotB:
1.0
Source:
CALCIPOTRIENE
(1993)
Small molecule
Vitamin D receptor agonist
TOPICAL
Approved
Psoriasis
CALCIPOTRIENE
×
Maximum Phase:
4
First Approval:
1993
UNII:
143NQ3779B
Molecule Type:
Small molecule
Molecular Formula:
C27H40O3
Molecular Weight:
412.61
AlogP:
5.09
PSA:
60.69
HBD:
3.0
HBA:
#RotB:
5.0
Source:
STRONTIUM CHLORIDE
(1993)
Small molecule
Unknown
Unknown
Approved
Unknown
STRONTIUM CHLORIDE
×
Maximum Phase:
4
First Approval:
1993
UNII:
EKE8PS9J6Z
Molecule Type:
Small molecule
Molecular Formula:
Cl2Sr
Molecular Weight:
158.53
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
TORSEMIDE
(1993)
Small molecule
Sodium-(potassium)-chloride cotransporter 2 inhibitor
INJECTION; ORAL
Approved
Cardiovascular Diseases; Heart Failure; Hypertension; Myocardial Infarction; Stroke
TORSEMIDE
×
Maximum Phase:
4
First Approval:
1993
UNII:
W31X2H97FB
Molecule Type:
Small molecule
Molecular Formula:
C16H20N4O3S
Molecular Weight:
348.43
AlogP:
2.53
PSA:
100.19
HBD:
3.0
HBA:
#RotB:
5.0
Source:
TRIMETREXATE GLUCURONATE
(1993)
Small molecule
Dihydrofolate reductase inhibitor
INJECTION
Approved
Unknown
TRIMETREXATE GLUCURONATE
×
Maximum Phase:
4
First Approval:
1993
UNII:
L137U4A79K
Molecule Type:
Small molecule
Molecular Formula:
C25H33N5O10
Molecular Weight:
563.56
AlogP:
2.74
PSA:
117.54
HBD:
3.0
HBA:
#RotB:
6.0
Source:
LEVOCABASTINE HYDROCHLORIDE
(1993)
Small molecule
Histamine H1 receptor antagonist
OPHTHALMIC
Approved
Unknown
LEVOCABASTINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
1993
UNII:
124XMA6YEI
Molecule Type:
Small molecule
Molecular Formula:
C26H30ClFN2O2
Molecular Weight:
456.99
AlogP:
4.89
PSA:
64.33
HBD:
1.0
HBA:
#RotB:
4.0
Source:
RIMANTADINE HYDROCHLORIDE
(1993)
Small molecule
Influenza virus A matrix protein M2 inhibitor
ORAL
Approved
Infections; Influenza, Human
RIMANTADINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
1993
UNII:
JEI07OOS8Y
Molecule Type:
Small molecule
Molecular Formula:
C12H22ClN
Molecular Weight:
215.77
AlogP:
2.55
PSA:
26.02
HBD:
1.0
HBA:
#RotB:
1.0
Source:
LEVOCABASTINE
(1993)
Small molecule
Unknown
Unknown
Approved
Eye Manifestations; Nasal Obstruction
LEVOCABASTINE
×
Maximum Phase:
4
First Approval:
1993
UNII:
COU3RRH769
Molecule Type:
Small molecule
Molecular Formula:
C26H29FN2O2
Molecular Weight:
420.53
AlogP:
4.89
PSA:
64.33
HBD:
1.0
HBA:
#RotB:
4.0
Source:
LEVOMETHADYL ACETATE
(1993)
Small molecule
Unknown
Unknown
Approved
Substance-Related Disorders
LEVOMETHADYL ACETATE
×
Maximum Phase:
4
First Approval:
1993
UNII:
R3B637Y991
Molecule Type:
Small molecule
Molecular Formula:
C23H31NO2
Molecular Weight:
353.51
AlogP:
4.65
PSA:
29.54
HBD:
0.0
HBA:
#RotB:
8.0
Source:
TAZOBACTAM SODIUM
(1993)
Small molecule
Bacterial beta-lactamase TEM inhibitor
Unknown
Approved
Appendicitis; Cellulitis; Diabetic Foot; Endometritis; Healthcare-Associated Pneumonia; Intraabdominal Infections; Pelvic Inflammatory Disease; Peritonitis; Pneumonia; Urinary Tract Infections
TAZOBACTAM SODIUM
×
Maximum Phase:
4
First Approval:
1993
UNII:
UXA545ABTT
Molecule Type:
Small molecule
Molecular Formula:
C10H11N4NaO5S
Molecular Weight:
322.28
AlogP:
-1.52
PSA:
122.46
HBD:
1.0
HBA:
#RotB:
3.0
Source:
GABAPENTIN
(1993)
Small molecule
Voltage-gated calcium channel modulator
ORAL
Approved
Epilepsy; Neuralgia, Postherpetic; Restless Legs Syndrome; Seizures
GABAPENTIN
×
Maximum Phase:
4
First Approval:
1993
UNII:
6CW7F3G59X
Molecule Type:
Small molecule
Molecular Formula:
C9H17NO2
Molecular Weight:
171.24
AlogP:
1.37
PSA:
63.32
HBD:
2.0
HBA:
#RotB:
3.0
Source:
PANTOTHENIC ACID
(1993)
Small molecule
Unknown
Unknown
Approved
Kidney Failure, Chronic
PANTOTHENIC ACID
×
Maximum Phase:
4
First Approval:
1993
UNII:
19F5HK2737
Molecule Type:
Small molecule
Molecular Formula:
C9H17NO5
Molecular Weight:
219.24
AlogP:
-1.04
PSA:
106.86
HBD:
4.0
HBA:
#RotB:
6.0
Source:
TACRINE
(1993)
Small molecule
Unknown
Unknown
Approved
Dementia
TACRINE
×
Maximum Phase:
4
First Approval:
1993
UNII:
4VX7YNB537
Molecule Type:
Small molecule
Molecular Formula:
C13H14N2
Molecular Weight:
198.27
AlogP:
2.7
PSA:
38.91
HBD:
1.0
HBA:
#RotB:
0.0
Source:
1
2
…
40
41
42
43
44
45
46
…
221
222
Next »
Download Option
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA